Insider · CIK 0001909362
Fred Aslan
ceopresidentofficerdirector
Files at ARTV (Artiva Biotherapeutics, Inc.). First filing Aug 18, 2025, latest Oct 7, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 8
$0 bought, $1.8M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ARTV: Artiva Biotherapeutics, Inc.
ARTVOct 9, 2026 · close 6.94
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 31Weak | Artiva Biotherapeutics, Inc. | $169k 23,463 shares | -2% | +165% from low-46% from high | |
| 56Moderate | Artiva Biotherapeutics, Inc. | $422k 61,696 shares | -4% | +160% from low-47% from high | |
| 33Weak | Artiva Biotherapeutics, Inc. | $256k 23,429 shares | -2% | - | |
| 61Notable | Artiva Biotherapeutics, Inc. | $690k 61,888 shares | -4% | - | |
| 5Weak | Artiva Biotherapeutics, Inc. | $19k 3,187 shares | -0% | +329% from low-43% from high | |
| 5Weak | Artiva Biotherapeutics, Inc. | $22k 6,375 shares | -2% | +139% from low-73% from high | |
| 16Weak | Artiva Biotherapeutics, Inc. | $153k 25,500 shares | -7% | +309% from low-58% from high | |
| 13Weak | Artiva Biotherapeutics, Inc. | $70k 25,500 shares | -6% | +87% from low-83% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | ARTV Artiva Biotherapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -23,463 | $7.20 | $169k | 1,519,606 | 5 d ago |
| Oct 5, 2026 | ARTV Artiva Biotherapeutics, Inc. | SOpen-market sale Common Stock | -61,696 | $6.84 | $422k | 1,543,069 | 6 d ago |
| Sep 15, 2026 | ARTV Artiva Biotherapeutics, Inc. | AGrant or award Common Stock | +110,000 | $0.00 | $0 | 1,604,765 | 27 d ago |
| Sep 15, 2026 | ARTV Artiva Biotherapeutics, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +315,000 | $0.00 | $0 | 315,000 | 27 d ago |
| Sep 10, 2026 | ARTV Artiva Biotherapeutics, Inc. | AGrant or award Common Stock | +45,000 | $0.00 | $0 | 1,494,765 | 28 d ago |
| Sep 10, 2026 | ARTV Artiva Biotherapeutics, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +155,000 | $0.00 | $0 | 155,000 | 28 d ago |
| Sep 8, 2026 | ARTV Artiva Biotherapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -23,429 | $10.92 | $256k | 1,449,765 | 33 d ago |
| Sep 3, 2026 | ARTV Artiva Biotherapeutics, Inc. | SOpen-market sale Common Stock | -61,888 | $11.16 | $690k | 1,473,194 | 38 d ago |
| Feb 15, 2026 | ARTV Artiva Biotherapeutics, Inc. | AGrant or award Common Stock | +366,850 | $0.00 | $0 | 1,576,798 | Feb 18, 2026 |
| Feb 15, 2026 | ARTV Artiva Biotherapeutics, Inc. | FTax withholding Common Stock | -14,600 | $4.00 | $58k | 1,562,198 | Feb 18, 2026 |
| Dec 15, 2025 | ARTV Artiva Biotherapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -3,187 | $6.00 | $19k | 1,209,948 | Dec 15, 2025 |
| Dec 12, 2025 | ARTV Artiva Biotherapeutics, Inc. | AGrant or award Common Stock | +869,136 | $0.00 | $0 | 1,213,135 | Dec 12, 2025 |
| Dec 12, 2025 | ARTV Artiva Biotherapeutics, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -100,577 | - | - | 0 | Dec 12, 2025 |
| Dec 12, 2025 | ARTV Artiva Biotherapeutics, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -51,463 | - | - | 0 | Dec 12, 2025 |
| Dec 12, 2025 | ARTV Artiva Biotherapeutics, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -257,319 | - | - | 0 | Dec 12, 2025 |
| Dec 12, 2025 | ARTV Artiva Biotherapeutics, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -26,450 | - | - | 0 | Dec 12, 2025 |
| Dec 12, 2025 | ARTV Artiva Biotherapeutics, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -113,999 | - | - | 0 | Dec 12, 2025 |
| Dec 12, 2025 | ARTV Artiva Biotherapeutics, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -319,331 | - | - | 0 | Dec 12, 2025 |
| Nov 15, 2025 | ARTV Artiva Biotherapeutics, Inc. | FTax withholding Common Stock10b5-1 | -6,347 | $3.25 | $21k | 350,374 | Nov 17, 2025 |
| Nov 17, 2025 | ARTV Artiva Biotherapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -6,375 | $3.38 | $22k | 343,999 | Nov 17, 2025 |
| Oct 17, 2025 | ARTV Artiva Biotherapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -25,500 | $6.00 | $153k | 356,721 | Oct 17, 2025 |
| May 15, 2025 | ARTV Artiva Biotherapeutics, Inc. | FTax withholding Common Stock10b5-1 | -4,472 | $2.13 | $9,525 | 412,193 | Aug 18, 2025 |
| Aug 15, 2025 | ARTV Artiva Biotherapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -25,500 | $2.73 | $70k | 386,693 | Aug 18, 2025 |
| Aug 15, 2025 | ARTV Artiva Biotherapeutics, Inc. | FTax withholding Common Stock10b5-1 | -4,472 | $2.75 | $12k | 382,221 | Aug 18, 2025 |
| Mar 5, 2025 | ARTV Artiva Biotherapeutics, Inc. | AGrant or award Common Stock | +200,000 | $0.00 | $0 | 416,665 | Mar 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.